Gamma Investing LLC Candel Therapeutics, Inc. Transaction History
Gamma Investing LLC
- $1.17 Trillion
- Q4 2024
A detailed history of Gamma Investing LLC transactions in Candel Therapeutics, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 64 shares of CADL stock, worth $555. This represents 0.0% of its overall portfolio holdings.
Number of Shares
64
Previous 29
120.69%
Holding current value
$555
Previous $201,000
176.62%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CADL
# of Institutions
56Shares Held
6.41MCall Options Held
109KPut Options Held
130K-
Northpond Ventures, LLC1.94MShares$16.8 Million48.35% of portfolio
-
Vanguard Group Inc Valley Forge, PA946KShares$8.21 Million0.0% of portfolio
-
Black Rock Inc. New York, NY823KShares$7.14 Million0.0% of portfolio
-
State Street Corp Boston, MA492KShares$4.27 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA449KShares$3.9 Million0.0% of portfolio
About Candel Therapeutics, Inc.
- Ticker CADL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,891,900
- Market Cap $251M
- Description
- Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...